Detalhe da pesquisa
1.
Safety, tolerability, pharmacokinetics, and immunogenicity of the therapeutic monoclonal antibody mAb114 targeting Ebola virus glycoprotein (VRC 608): an open-label phase 1 study.
Lancet
; 393(10174): 889-898, 2019 03 02.
Artigo
Inglês
| MEDLINE | ID: mdl-30686586
2.
Neutralizing Alpha-Toxin Accelerates Healing of Staphylococcus aureus-Infected Wounds in Nondiabetic and Diabetic Mice.
Antimicrob Agents Chemother
; 62(3)2018 03.
Artigo
Inglês
| MEDLINE | ID: mdl-29311091
3.
A single amino acid in the F2 subunit of respiratory syncytial virus fusion protein alters growth and fusogenicity.
J Gen Virol
; 94(Pt 12): 2627-2635, 2013 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-24092758
4.
Safety and immunogenicity of a ferritin nanoparticle H2 influenza vaccine in healthy adults: a phase 1 trial.
Nat Med
; 28(2): 383-391, 2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-35115706
5.
Recombinant respiratory syncytial virus F protein expression is hindered by inefficient nuclear export and mRNA processing.
Virus Genes
; 40(2): 212-21, 2010 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-20111897
6.
Human cytomegalovirus uracil DNA glycosylase associates with ppUL44 and accelerates the accumulation of viral DNA.
Virol J
; 2: 55, 2005 Jul 15.
Artigo
Inglês
| MEDLINE | ID: mdl-16022730
7.
Palivizumab epitope-displaying virus-like particles protect rodents from RSV challenge.
J Clin Invest
; 125(4): 1637-47, 2015 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-25751145
8.
A host-range restricted parainfluenza virus type 3 (PIV3) expressing the human metapneumovirus (hMPV) fusion protein elicits protective immunity in African green monkeys.
Vaccine
; 23(14): 1657-67, 2005 Feb 25.
Artigo
Inglês
| MEDLINE | ID: mdl-15705469
9.
Parainfluenza virus type 3 expressing the native or soluble fusion (F) Protein of Respiratory Syncytial Virus (RSV) confers protection from RSV infection in African green monkeys.
J Virol
; 78(20): 11198-207, 2004 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-15452239